Most preclinical imaging asks you to trade something for the picture. Radiation dose limits how often you can scan the same animal. Contrast agents change the physiology you are trying to observe. Anaesthesia time adds up across a longitudinal study.
High-frequency ultrasound sidesteps much of that. It is real time, it needs no radiation and no contrast agent, and you can repeat it as often as the protocol requires.
What it measures
Preclinical ultrasound systems transmit ultrasound and reconstruct live images from the returning echoes, resolving soft tissue, vasculature and organs. At the high frequencies used for rodents, structures resolve down to roughly 30 µm — fine enough to image mouse embryos as early as 6.5 days.
Three measurement types cover most of the work:
- Structure and volume — tumour, heart, kidney and liver dimensions, tracked over time in the same animal
- Blood flow — Doppler measurement of direction and velocity in vessels and the heart, which is central to cardiac and renal function studies and to characterising a tumour microenvironment
- Tissue stiffness — derived from the speed of ultrasound propagation, often indicating fibrosis or other pathology
The one measurement nothing else gives you
Ultrasound is the only method that measures blood flow in real time without any contrast agent. For haemodynamics that is not a convenience, it is the whole capability — anything requiring an injected agent measures a perturbed system, and anything requiring gating or reconstruction is not watching the flow as it happens.
Where contrast is wanted, microbubbles extend the technique into kinetics and biodistribution rather than replacing the native measurement.
Why longitudinal studies benefit most
Because there is no dose, the same animal can be imaged as often as the question requires. That changes study design in two ways: each animal becomes its own control, removing between-subject variability, and fewer animals are needed for the same statistical power. For studies where the interesting behaviour is a trajectory rather than an endpoint, that is usually decisive.
Where ultrasound is the wrong tool
Molecular and metabolic questions. Ultrasound reports structure and flow, not tracer uptake or gene expression. That is PET or SPECT, or optical reporter imaging.
Bone and mineralised tissue. Ultrasound does not penetrate bone usefully — that is X-ray-based imaging.
Anything behind gas or bone. Lung and much of the skull are effectively inaccessible.
Practicalities
Modern preclinical systems are compact and tablet-based, which puts them within reach of an individual laboratory rather than only a shared imaging core. For groups doing regular cardiac, tumour or developmental work, imaging on your own schedule instead of booking core time tends to change how much imaging actually gets done.
Merkel Technologies supplies preclinical ultrasound in Israel with local training and service — talk to us.